Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

48.71 -0.85 (-1.72%)

Streaming Delayed Price Updated: 11:32 AM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction ↗

August 11, 2025

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA vaccine oversight.

Via Benzinga

The 3 Things That Matter for Moderna Now ↗

August 11, 2025

The company is still trying to prove that it isn't just a pandemic play.

Via The Motley Fool

3 Cash-Burning Stocks That Fall Short

August 11, 2025

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.

Via StockStory

RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies' ↗

August 06, 2025

The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million.

Via Benzinga

Moderna's Earnings: A Preview ↗

July 31, 2025

Via Benzinga

1 S&P 500 Stock to Consider Right Now and 2 Facing Headwinds

August 06, 2025

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...

Via StockStory

Topics Stocks

Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca ↗

August 05, 2025

Via Stocktwits

Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio? ↗

August 03, 2025

Ten large-cap stocks, including Novo Nordisk and UPS, tumbled last week on weak earnings and guidance cuts.

Via Benzinga

Discover which S&P500 stocks are making waves on Friday. ↗

August 01, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.

Via Chartmill

Stay informed with the top movers within the S&P500 index on Friday. ↗

August 01, 2025

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Friday as we examine the latest happenings in today's session.

Via Chartmill

Why Moderna (MRNA) Stock Is Trading Lower Today

August 01, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.1% in the afternoon session after the company trimmed the upper end of its 2025 revenue forecast, citing a delay in vaccine shipments. The...

Via StockStory

Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector ↗

August 01, 2025

Shares of Novavax are trading lower Friday morning. The stock appears to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna reported disappointing Q2 results.

Via Benzinga

Which S&P500 stocks are gapping on Friday? ↗

August 01, 2025

Curious about the market action on Friday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Moderna CEO Attributes Full-Year Revenue Guidance Reduction To Timing Of Shipments: Retail Pins Hopes On Pipeline After Q2 Beat ↗

August 01, 2025

The vaccine maker lowered its full-year revenue guidance to a range of $1.5 billion to $2.2 billion, reflecting a $300 million reduction at the high end of the range.

Via Stocktwits

Topics Artificial Intelligence

Moderna's Key Patent Win Overshadowed By Gloomy Outlook ↗

August 01, 2025

Moderna beat Q2 earnings and revenue estimates, narrowed its annual forecast, won a key patent case, and plans to cut 10% of its global workforce.

Via Benzinga

Topics Intellectual Property

Top S&P500 movers in Friday's pre-market session ↗

August 01, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Friday?

Via Chartmill

Moderna (NASDAQ:MRNA) Exceeds Q2 Expectations But Stock Drops

August 01, 2025

Biotechnology company Moderna (NASDAQ:MRNA) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 41.1% year on year to $142 million. On the other hand, the...

Via StockStory

Moderna Stock Falls Again Amid Lowered Guidance, Job Cuts ↗

August 01, 2025

The biotech reported a smaller-than-expected Q2 loss and revenue decline.

Via Investor's Business Daily

Topics Artificial Intelligence

Dow Futures Decline As Trump Unleashes Tariffs Globally: AAPL, AMZN, COIN, RDDT, CVX, XOM Among Stocks To Watch ↗

August 01, 2025

While Dow Jones futures were down 0.94% at the time of writing, the S&P 500 futures fell 0.95%.

Via Stocktwits

Topics ETFs Government Stocks

Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates

August 01, 2025

Via ACCESS Newswire

UK Court of Appeal Confirms Moderna’s EP'949 Patent is Valid and Infringed by Pfizer/BioNTech

August 01, 2025

Via ACCESS Newswire

Moderna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

August 01, 2025

Via Benzinga

Earnings Scheduled For August 1, 2025 ↗

August 01, 2025

Via Benzinga

Moderna Announces 10% Layoffs Ahead Of Q2 Report: Retail Now Eyes ‘Good Enough’ Earnings ↗

July 31, 2025

CEO Stéphane Bancel said in a note to employees on Thursday that the move is part of the company’s commitment to reduce annual operating expenses by about $1.5 billion by 2027.

Via Stocktwits

Topics Artificial Intelligence Supply Chain Workforce

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles ↗

July 31, 2025

Moderna Inc. (NASDAQ: MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Via Benzinga

Moderna Earnings: What To Look For From MRNA

July 30, 2025

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Government World Trade

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

July 30, 2025

Via ACCESS Newswire

Oscar Health, Surgery Partners, Moderna, Molina Healthcare, and Fortrea Stocks Trade Down, What You Need To Know

July 29, 2025

A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending...

Via StockStory

Uncover the latest developments among S&P500 stocks in today's session. ↗

July 29, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption' ↗

July 28, 2025

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), describing the system as fundamentally broken...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.